Evolution of vital quasispecies in interferon-treated patients with chronic hepatitis C virus infection

Journal of Hepatology

Volumn 31, Issue 4, 1999, Pages 618-627

  Hassoba, Howayda M ^a   Bzowej, Natalie ^a   Berenguer, Marina ^a   Kim, Michael ^a   Zhou, Shuan ^c   Phung, Yume ^a   Grant, Robert ^a   Pessoa, Mario G ^a   Wright, Teresa L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Gastroenterology Section 111B   (United States)

^c NONE

Author keywords

Hepatitis C virus; Heteroduplex mobility assay; Hypervariable region; Interferon; Phylogenetic analysis; Quasispecies

Indexed keywords

INTERFERON; ANTIVIRUS AGENT;

AMINO ACID SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; HEPATITIS C; HUMAN; MUTATION; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TREATMENT FAILURE; VIRUS STRAIN; DRUG RESISTANCE; EVOLUTION; GENETIC VARIABILITY; GENETICS; HEPATITIS C VIRUS; HETERODUPLEX ANALYSIS; MOLECULAR GENETICS; REFERENCE VALUE; VIROLOGY;

AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; DRUG RESISTANCE; EVOLUTION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HETERODUPLEX ANALYSIS; HUMANS; INTERFERONS; MOLECULAR SEQUENCE DATA; REFERENCE VALUES; VARIATION (GENETICS);

EID: 0032590234     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80340-7     Document Type: Article

References (28)

1. Martell M, Esteban JI, Quer J, Vargas V, Esteban R, Guardia J, et al. Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation. J Virol. 68:1994;3425-3436.
2. Oshima M, Tsuchiya M, Yagasaki M, Orita T, Hasegawa M, Tomonoh K, et al. cDNA clones of Japanese hepatitis C virus genomes derived from a single patient show sequence heterogeneity. J Gen Virol. 72:1991;2805-2809.
3. Murakawa k, Esumi M, Kato T, Kambara H, Shitaka K. Heterogeneity within the nonstructural protein 5-encoding region of hepatitis C viruses from a single patient. Gene. 117:1992;229-232.
4. Higashi Y, Kakumu S, Yoshioka K, Wakita T, Misokami M, Ohba K, et al. Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology. 197:1993;659-668.
5. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci. 89:1992;3468-3472.
6. Tanigushi S, Okamoto H, Sakamoto M, Kojima M, Tsuda F, Tanaka T, et al. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology. 105:1993;297-301.
7. Dienstag JL. Management of chronic hepatitis C: a consensus. Gastroenterology. 113:1997;375.
8. Gonzalez-Peralta R, Qian K, She J, Davis G, Ohno T, Mizokami M, Jyn L. Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C. J Med Virol. 49:1996;242-247.
9. Le Guen B, Squadrito G, Nalpas B, Berthelot P, Pol S, Brechot C. Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C. Hepatology. 25:1997;1250-1254.
10. Koizumi K, Enomoto N, Kurosaki M, Murakami T, Izumi N, Marumo F, et al. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology. 22:1995;30-35.
11. Okada S, Akahane Y, Suzuki H, Okamoto H, Mishiro S. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology. 16:1992;619-624.
12. Toyoda H, Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T, et al. Quasispecies nature of hepatitis C virus and response to alpha interferon: significance as a predictor of direct response to interferon. J Hepatol. 26:1997;6-13.
13. Polyak S, Faulkner G, Carithers R Jr., Corey L, Gretch D. Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis: correlation with response to interferon therapy. JID. 175:1997;1101-1107.
14. Delwart E, Shpaer E, Louwagie J, McCutchan E, Grez M, Rubsamen-Waigmann H, et al. Genetic relationships determined by a DNA heteroduplex mobility assay; analysis of HIV-1 env genes. Science. 262:1993;1257-1260.
15. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA. 86:1989;2766-2770.
16. Gretch DR, Polyak SJ, Wilson JJ, Carithers RL Jr., Perkins JD, Corey L. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J Virol. 70:1996;7622-7631.
17. Wilson J, Polyak S, Day T, Gretch D. Characterization of simple and complex hepatitis C virus quasispecies by heteroduplex gel shift analysis: correlation with nucleotide sequencing. J Gen Virol. 76:1995;1763-1771.
18. Polyak S, McArdle S, Liu S-L, Sullivan D, Chung M, Hofgartner W, et al. Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection. J Virol. 72:1998;4288-4296.
19. Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology. 106:1994;994-999.
20. Davidson F, Simmonds P, Ferguson J, Jarvis L, Dow B, Follett A, et al. Survey of major genotypes and subtypes of hepatitis C using RFLP of sequences amplified from the 5′ non-coding region. J Gen Virol. 76:1995;1197-1204.
21. Zhou S, Terrault N, Ferrell L, Hahn JA, Lau JY, Simmonds P, et al. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology. 24:1996;1041-1046.
22. Simmonds P, Alberti A, Alter H, Bonino F, Bradley D, Brechot C, et al. A proposed system for the nomenclature of hepatitis C virus genotypes. Hepatology. 19:1994;1321-1324.
23. Pessoa M, Bzowej NH, Kim M, Phung Y, Ferrell L, Ascher N, et al. HCV quasispecies as a mechanism of severe post-transplantation (OLT) recurrence. [abstract] Hepatology. 28:1998;165A.
24. Thompson J, Higgins D, Gibson T, Clustal W. Improving sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:1994;4673-4680.
25. Felsenstein J. Evolutionary trees from DNA sequences: a maximum likelihood approach. J Mol Evol. 17:1981;368-376.
26. Enomoto N, Sato C, Kurosaki M, Marumo F. Hepatitis C virus after interferon treatment has the variation in the hypervariable region of the envelope 2 gene. J Hepatol. 20:1994;252-261.
27. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med. 334:1996;77-81.
28. Pawlotsky J, Pellerin M, Bouvier M, Roudot-Thoraval F, Germanidis G, Bastie A, et al. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C. J Med Virol. 54:1998;256-264.